Bioera S.P.A. Announced earnings results for the half year ended June 30, 2021. For the half year, the company announced total revenue was EUR 19.254 million compared to EUR 7.063 million a year ago. Operating income was EUR 17.382 million compared to operating loss of EUR 2.036 million a year ago. Net income was EUR 3.741 million compared to net loss of EUR 875,000 a year ago. Basic earnings per share from continuing operations was EUR 0.33 compared to basic loss per share from continuing operations of EUR 0.15 a year ago. Diluted earnings per share from continuing operations was EUR 0.2 compared to diluted loss per share from continuing operations of EUR 0.4 a year ago.